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One of the first comprehensive reviews 
of the capacity and performance of any 
public sector ARV sites countrywide 
reveals that less than 20% of patients 
began ARV treatment within 3 months 
of referral – the period in which most 
deaths occur.
This has massive national 
implications for AIDS mortality and, 
in the opinion of some of the country’s 
top HIV/AIDS experts, can be relatively 
easily addressed by a fundamental shift 
in approach. The latest evidence boosts 
their calls for the horizontal integration 
of officially accredited ARV sites into 
the overall primary health care system 
to speed up drug access for desperate 
people living with HIV/AIDS.
Clinicians on the ground have 
repeatedly asserted that HIV testing, 
CD4 staging, opportunistic illness 
prevention and drug readiness training 
can be adequately done at non-ARV-
accredited primary health care sites, 
thus saving countless lives. Patients 
having had this ‘work up’ can then be 
referred to an official ARV site for their 
drugs.
With doctor shortages at an all-time 
high (an estimated 70% of posts empty 
at most rural hospitals), the health 
department’s insistence on rolling 
out ARVs only at the 362 accredited 
sites plus its reluctance to shift less 
complicated ARV drug prescribing to 
adequately trained nurses is causing 
deadly bottlenecks in delivery.
Described by Dr Francois Venter, 
chief of the Southern African HIV 
Clinicians Society as ‘an excellent 
piece of operational research’, the new 
study is of four Comprehensive Care 
Management and Treatment (CCMT) 
sites in Gauteng.
Until now most evidence on the 
feasibility and outcomes of ARV 
provision in South Africa has come from 
‘innovator’ NGO programmes, led by 
motivated champions with external 
donor funding. The public sector has 
largely escaped expert examination.
Published by the Centre for Health 
Policy at the University of the 
Witwatersrand in January this year, 
the research, conducted on ‘second-
generation’ 2-year-old CCMT roll-out 
sites in 2006, reported patient saturation 
already present at two of the sites.
Overwhelm imminent 
There was ‘a rapid growth in numbers’, 
and expansion was ‘continuing 
unabated’. Space and staff shortages 
were resulting in a waiting list for 
treatment initiation in one site, 
patients being turned away from the 
pharmacy in another, services being 
cut back and general staff burnout and 
dissatisfaction.
The authors said that because of these 
findings, it was ‘distinctly possible’ 
that some of the good performances 
observed in the study would not be 
maintained. There was a disturbingly 
high rate of loss to follow up, reaching 
30% at one site. In the short term, 
attention to improving chronic disease 
care systems, such as simplified follow-
up protocols, reorganisation of roles 
and task shifting, improving patient 
flow and, importantly, designing better 
monitoring and evaluation processes, 
would create efficiencies, allowing for 
larger numbers to be seen without loss 
of quality.
In the medium term however, the 
CCMT programme faced ‘a demand that 
vastly outstrips supply’. The current 
model, based on dedicated CCMT sites 
in a few facilities, was unlikely to meet 
demand, much less need. ‘There is 
now considerable evidence across the 
country of the feasibility of integrated, 
district-based approaches that mobilise 
the whole health care infrastructure and 
which achieve universal access while 
maintaining quality and outcomes,’ they 
concluded.
Scaling up such models would require 
a new cycle of planning that addressed, 
among other things, the need for 
new frameworks, methodologies and 
training, particularly comprehensive 
district-based approaches. Reviewing 
human resource policies and norms 
for the primary health care system, 
including core staff establishments to 
cater for expanded functions at this 
level, was vital.
Nurses the ‘core’ of delivery
When the data were collected in 2006, 
each site ranged from 600 to 1 700 
patients and health care staff saw 50 - 
200 people a day. In terms of the norms 
set by the national CCMT plan, three 
of the sites had staffing shortfalls while 
all of them experienced a turnover of 
doctors and shortages of pharmacists, 
dieticians and social workers.Nurses 
formed the stable core of the sites and 
were key to setting the ‘tone’ of the 
service.
The study highlighted the clinical 
excellence of a public health approach, 
very high levels of treatment literacy 
(78 - 93% could state their latest CD4 
result) and high disclosure rates, plus 
the constructive role of families in 
social support. Over 90% of patients 
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agreed with the statements ‘the health 
care workers I see cares about me’, and 
‘the health worker provided you with 
feedback on whether the drugs were 
working or not’.
Within sites, VCT, TB, staging 
and ARV services, if not physically 
integrated, were managed closely 
together, making it relatively easy for 
patients to move from one service point 
to another. All sites had active systems 
of treatment preparation and adherence 
management while laboratory and drug 
supply systems functioned smoothly. 
Despite a plethora of reports and forms, 
monitoring and evaluation systems 
were ‘weak’ across sites. 
Transport costs incurred in attending 
services were about R18 per visit at the 
community health centres and between 
R25 and R37 at the two hospitals. 
Patients spent between 4 and 6 hours at 
the clinic for each visit.
Venter said after studying the report 
that ‘a lot of recent research, including 
from UCT, has shown that most deaths 
on the ARV treatment programme occur 
during the wait to access ARV treatment 
after referral’. Gauteng, together with 
KwaZulu-Natal, had the most number 
of patients on ARV in South Africa, 
making the study particularly relevant.
He picked out the poor use of viral 
loads to guide treatment, the lack of 
service integration and poor monitoring 
and evaluation findings of the study 
as eloquent testimony of country-wide 
problems. Venter said the poor use 
of viral loads to guide treatment was 
of concern as the test was ‘expensive 
and operationally complex’. There was 
minimal evidence of health worker ‘task 
shifting,’ and an abundance of evidence 
of the ongoing human resource 
dilemma. 
The document raised many operation 
issues, demonstrated the strength of 
a public health approach (excellent 
clinical results), the lack of mechanisms 
to chase down defaulters and the lack 
of urgency in ARV treatment initiation. 
The gender and age breakdown 
suggested that men and the youth were 
still not accessing these services.
‘This is a hugely reflective and useful 
report. Now we need to discuss how to 
deal with these challenges,’ he added.
The government’s ambitious ARV 
rollout, aimed at universal access within 
5 years, was launched in 2004. With 
less than half the people reached by the 
beginning of this year (ASSA estimates), 
the target date has now been revised to 
2011.
Chris Bateman
pg246-256.indd   244 3/26/08   3:25:30 PM
